vs

Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and Sila Realty Trust, Inc. (SILA). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $50.1M, roughly 1.7× Sila Realty Trust, Inc.). Sila Realty Trust, Inc. runs the higher net margin — 10.0% vs -38.1%, a 48.1% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 7.6%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -0.6%).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

Sila Realty Trust, Inc. is a U.S.-based real estate investment trust that owns, operates, and acquires high-quality income-generating commercial properties. Its core portfolio covers industrial logistics facilities, office assets and mixed-use properties, serving tenants across logistics, corporate and retail segments to deliver stable long-term returns.

PRCT vs SILA — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.7× larger
PRCT
$83.1M
$50.1M
SILA
Growing faster (revenue YoY)
PRCT
PRCT
+12.6% gap
PRCT
20.2%
7.6%
SILA
Higher net margin
SILA
SILA
48.1% more per $
SILA
10.0%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-0.6%
SILA

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
PRCT
PRCT
SILA
SILA
Revenue
$83.1M
$50.1M
Net Profit
$-31.6M
$5.0M
Gross Margin
64.9%
88.9%
Operating Margin
-4.1%
Net Margin
-38.1%
10.0%
Revenue YoY
20.2%
7.6%
Net Profit YoY
-27.9%
-54.9%
EPS (diluted)
$-0.56
$0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRCT
PRCT
SILA
SILA
Q1 26
$83.1M
Q4 25
$76.4M
$50.1M
Q3 25
$83.3M
$49.8M
Q2 25
$79.2M
$48.7M
Q1 25
$69.2M
$48.3M
Q4 24
$68.2M
$46.5M
Q3 24
$58.4M
$46.1M
Q2 24
$53.4M
$43.6M
Net Profit
PRCT
PRCT
SILA
SILA
Q1 26
$-31.6M
Q4 25
$-29.8M
$5.0M
Q3 25
$-21.4M
$11.6M
Q2 25
$-19.6M
$8.6M
Q1 25
$-24.7M
$7.9M
Q4 24
$-18.9M
$11.1M
Q3 24
$-21.0M
$11.9M
Q2 24
$-25.6M
$4.6M
Gross Margin
PRCT
PRCT
SILA
SILA
Q1 26
64.9%
Q4 25
60.6%
88.9%
Q3 25
64.8%
88.1%
Q2 25
65.4%
87.7%
Q1 25
63.9%
86.9%
Q4 24
64.0%
87.3%
Q3 24
63.2%
87.4%
Q2 24
59.0%
86.6%
Operating Margin
PRCT
PRCT
SILA
SILA
Q1 26
-4.1%
Q4 25
-40.6%
Q3 25
-27.8%
Q2 25
-28.0%
Q1 25
-39.7%
Q4 24
-28.9%
Q3 24
-38.4%
Q2 24
-50.3%
Net Margin
PRCT
PRCT
SILA
SILA
Q1 26
-38.1%
Q4 25
-39.1%
10.0%
Q3 25
-25.7%
23.3%
Q2 25
-24.7%
17.6%
Q1 25
-35.8%
16.4%
Q4 24
-27.6%
23.9%
Q3 24
-35.9%
25.9%
Q2 24
-48.0%
10.6%
EPS (diluted)
PRCT
PRCT
SILA
SILA
Q1 26
$-0.56
Q4 25
$-0.54
$0.10
Q3 25
$-0.38
$0.21
Q2 25
$-0.35
$0.15
Q1 25
$-0.45
$0.14
Q4 24
$-0.34
$0.20
Q3 24
$-0.40
$0.21
Q2 24
$-0.50
$0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRCT
PRCT
SILA
SILA
Cash + ST InvestmentsLiquidity on hand
$245.6M
$32.3M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$347.7M
$1.3B
Total Assets
$487.1M
$2.1B
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRCT
PRCT
SILA
SILA
Q1 26
$245.6M
Q4 25
$286.5M
$32.3M
Q3 25
$294.3M
$27.7M
Q2 25
$302.7M
$24.8M
Q1 25
$316.2M
$30.5M
Q4 24
$333.7M
$39.8M
Q3 24
$196.8M
$28.6M
Q2 24
$214.1M
$87.0M
Total Debt
PRCT
PRCT
SILA
SILA
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
PRCT
PRCT
SILA
SILA
Q1 26
$347.7M
Q4 25
$365.9M
$1.3B
Q3 25
$380.3M
$1.3B
Q2 25
$385.8M
$1.4B
Q1 25
$389.2M
$1.4B
Q4 24
$402.2M
$1.4B
Q3 24
$241.2M
$1.4B
Q2 24
$251.8M
$1.5B
Total Assets
PRCT
PRCT
SILA
SILA
Q1 26
$487.1M
Q4 25
$508.1M
$2.1B
Q3 25
$511.5M
$2.1B
Q2 25
$513.1M
$2.0B
Q1 25
$519.4M
$2.0B
Q4 24
$534.0M
$2.0B
Q3 24
$374.1M
$2.0B
Q2 24
$374.4M
$2.1B
Debt / Equity
PRCT
PRCT
SILA
SILA
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRCT
PRCT
SILA
SILA
Operating Cash FlowLast quarter
$119.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
23.76×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRCT
PRCT
SILA
SILA
Q1 26
Q4 25
$-10.3M
$119.1M
Q3 25
$-6.6M
$30.0M
Q2 25
$-15.0M
$31.9M
Q1 25
$-17.0M
$24.1M
Q4 24
$-32.4M
$132.8M
Q3 24
$-18.8M
$29.1M
Q2 24
$-15.7M
$31.6M
Free Cash Flow
PRCT
PRCT
SILA
SILA
Q1 26
Q4 25
$-12.2M
Q3 25
$-9.5M
Q2 25
$-17.8M
Q1 25
$-18.8M
Q4 24
$-33.6M
Q3 24
$-19.0M
Q2 24
$-16.8M
FCF Margin
PRCT
PRCT
SILA
SILA
Q1 26
Q4 25
-15.9%
Q3 25
-11.4%
Q2 25
-22.5%
Q1 25
-27.2%
Q4 24
-49.2%
Q3 24
-32.6%
Q2 24
-31.4%
Capex Intensity
PRCT
PRCT
SILA
SILA
Q1 26
Q4 25
2.4%
Q3 25
3.4%
Q2 25
3.5%
Q1 25
2.7%
Q4 24
1.7%
Q3 24
0.4%
Q2 24
2.0%
Cash Conversion
PRCT
PRCT
SILA
SILA
Q1 26
Q4 25
23.76×
Q3 25
2.59×
Q2 25
3.71×
Q1 25
3.06×
Q4 24
11.95×
Q3 24
2.43×
Q2 24
6.84×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

SILA
SILA

Segment breakdown not available.

Related Comparisons